US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

6.290
-0.350-5.27%

Close Aug 9 16:00 ET

6.350
+0.060+0.95%

Post 19:59 ET

1.77BMarket Cap-3789P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.87%-82.22M

-39.53%-102.3M

-244.55%-287.78M

-65.54%-74.08M

-33.70%-72.92M

-9.48%-67.47M

-194.74%-73.32M

47.34%-83.52M

26.83%-44.75M

-65.04%-54.54M

Net income from continuing operations

-27.13%-97.54M

-39.87%-91.37M

-36.99%-328.07M

-61.75%-93M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

-28.42%-239.48M

11.46%-57.49M

-27.45%-60.45M

Depreciation and amortization

61.79%8.97M

97.88%7.38M

107.57%24.4M

135.00%7.55M

153.53%7.58M

98.96%5.54M

34.73%3.73M

39.87%11.76M

43.74%3.21M

22.70%2.99M

Other non cash items

-95.41%93K

-29.29%1.91M

33.76%11.45M

168.88%6.55M

-90.41%170K

-8.20%2.03M

26.12%2.7M

108.93%8.56M

110.54%2.44M

282.11%1.77M

Change In working capital

-1.41%-10.26M

-49.36%-36.45M

-147.90%-50.26M

-1,775.21%-11.27M

42.54%-4.46M

-6.12%-10.12M

-119.87%-24.4M

34,387.91%104.92M

84.82%-601K

-206.52%-7.77M

-Change in receivables

190.42%736K

-228.08%-1.04M

-387,700.00%-7.76M

-215.25%-6.42M

-105.37%-203K

54.78%-814K

95.80%-317K

99.96%-2K

306.72%5.57M

186.15%3.78M

-Change in payables and accrued expense

-10.45%4.26M

-88.89%-17.96M

392.53%8.44M

-50.65%4.78M

131.91%8.41M

207.30%4.76M

27.67%-9.51M

-88.63%1.71M

442.35%9.69M

-74.42%3.63M

-Change in other current liabilities

12.47%-2.62M

-55.24%-3.79M

-38.71%-9.86M

12.41%-1.91M

-18.58%-2.51M

-93.79%-3M

-93.20%-2.44M

---7.11M

---2.18M

---2.12M

-Change in other working capital

-14.19%-12.64M

-12.54%-13.66M

-137.23%-41.08M

43.58%-7.72M

22.16%-10.16M

-43.01%-11.07M

-108.38%-12.13M

1,203.20%110.32M

-447.00%-13.68M

-422.12%-13.05M

Cash from discontinued investing activities

Operating cash flow

-21.87%-82.22M

-39.53%-102.3M

-244.55%-287.78M

-65.54%-74.08M

-33.70%-72.92M

-9.48%-67.47M

-194.74%-73.32M

47.34%-83.52M

26.83%-44.75M

-65.04%-54.54M

Investing cash flow

Cash flow from continuing investing activities

-103.70%-4.18M

-24.59%-6.65M

-105.29%-10.23M

68.82%-2.49M

-100.65%-347K

-141.56%-2.05M

-103.73%-5.34M

171.11%193.25M

84.73%-7.98M

127.33%52.98M

Net PPE purchase and sale

70.21%-1.18M

-28.56%-6.65M

67.74%-11.96M

74.09%-2.07M

90.98%-745K

75.92%-3.97M

-19.18%-5.18M

6.88%-37.06M

-78.74%-7.98M

14.87%-8.26M

Net intangibles purchase and sale

---3M

--0

-99.00%-597K

---350K

72.67%-82K

--0

---165K

---300K

--0

---300K

Net business purchase and sale

----

--1.84M

---71K

--0

----

--0

Net investment purchase and sale

----

-99.79%480K

--0

----

199.42%230.61M

--0

133.42%61.55M

Cash from discontinued investing activities

Investing cash flow

-103.70%-4.18M

-24.59%-6.65M

-105.29%-10.23M

68.82%-2.49M

-100.65%-347K

-141.56%-2.05M

-103.73%-5.34M

171.11%193.25M

84.73%-7.98M

127.33%52.98M

Financing cash flow

Cash flow from continuing financing activities

6,848.03%263.12M

623.05%13.9M

-9.21%140.13M

-45.23%80.66M

2,200.60%53.77M

41.94%3.79M

-7.77%1.92M

-66.34%154.35M

3,779.24%147.26M

121.06%2.34M

Net issuance payments of debt

-8.33%-26K

-751.11%-766K

-2,917.39%-694K

-4.35%-24K

-9.09%-24K

99.30%-90K

-9.52%-23K

99.82%-23K

Net common stock issuance

--261.55M

--10.87M

-10.87%128.09M

-45.66%78.09M

--50M

--0

-68.95%143.71M

--143.71M

----

Proceeds from stock option exercised by employees

-57.96%1.6M

56.73%3.05M

19.41%12.81M

-8.63%3.26M

60.55%3.79M

41.67%3.81M

-7.60%1.95M

27.11%10.72M

-6.52%3.57M

43.73%2.36M

Cash from discontinued financing activities

Financing cash flow

6,848.03%263.12M

623.05%13.9M

-9.21%140.13M

-45.23%80.66M

2,200.60%53.77M

41.94%3.79M

-7.77%1.92M

-66.34%154.35M

3,779.24%147.26M

121.06%2.34M

Net cash flow

Beginning cash position

-36.53%306.15M

-28.20%401.43M

89.31%559.11M

-14.56%397.21M

-10.19%416.82M

-6.90%482.38M

89.31%559.11M

10.55%295.35M

14.80%464.89M

-27.82%464.11M

Current changes in cash

368.85%176.72M

-23.88%-95.06M

-159.79%-157.88M

-95.67%4.09M

-2,600.26%-19.5M

-21.69%-65.73M

-134.44%-76.73M

837.02%264.07M

186.25%94.53M

100.33%780K

Effect of exchange rate changes

-165.19%-118K

-10,850.00%-219K

161.24%188K

140.39%124K

---115K

--181K

---2K

---307K

--0

End cash Position

15.82%482.75M

-36.53%306.15M

-28.20%401.43M

-14.56%397.21M

-10.19%416.82M

-6.90%482.38M

89.31%559.11M

14.80%464.89M

Free cash flow

-20.95%-86.4M

-38.52%-108.95M

-148.45%-300.33M

-45.08%-76.49M

-16.87%-73.75M

8.53%-71.44M

-207.68%-78.66M

39.07%-120.88M

19.65%-52.73M

-47.60%-63.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.87%-82.22M	-39.53%-102.3M	-244.55%-287.78M	-65.54%-74.08M	-33.70%-72.92M	-9.48%-67.47M	-194.74%-73.32M	47.34%-83.52M	26.83%-44.75M	-65.04%-54.54M
Net income from continuing operations	-27.13%-97.54M	-39.87%-91.37M	-36.99%-328.07M	-61.75%-93M	-53.89%-93.02M	-17.03%-76.73M	-16.70%-65.33M	-28.42%-239.48M	11.46%-57.49M	-27.45%-60.45M
Depreciation and amortization	61.79%8.97M	97.88%7.38M	107.57%24.4M	135.00%7.55M	153.53%7.58M	98.96%5.54M	34.73%3.73M	39.87%11.76M	43.74%3.21M	22.70%2.99M
Other non cash items	-95.41%93K	-29.29%1.91M	33.76%11.45M	168.88%6.55M	-90.41%170K	-8.20%2.03M	26.12%2.7M	108.93%8.56M	110.54%2.44M	282.11%1.77M
Change In working capital	-1.41%-10.26M	-49.36%-36.45M	-147.90%-50.26M	-1,775.21%-11.27M	42.54%-4.46M	-6.12%-10.12M	-119.87%-24.4M	34,387.91%104.92M	84.82%-601K	-206.52%-7.77M
-Change in receivables	190.42%736K	-228.08%-1.04M	-387,700.00%-7.76M	-215.25%-6.42M	-105.37%-203K	54.78%-814K	95.80%-317K	99.96%-2K	306.72%5.57M	186.15%3.78M
-Change in payables and accrued expense	-10.45%4.26M	-88.89%-17.96M	392.53%8.44M	-50.65%4.78M	131.91%8.41M	207.30%4.76M	27.67%-9.51M	-88.63%1.71M	442.35%9.69M	-74.42%3.63M
-Change in other current liabilities	12.47%-2.62M	-55.24%-3.79M	-38.71%-9.86M	12.41%-1.91M	-18.58%-2.51M	-93.79%-3M	-93.20%-2.44M	---7.11M	---2.18M	---2.12M
-Change in other working capital	-14.19%-12.64M	-12.54%-13.66M	-137.23%-41.08M	43.58%-7.72M	22.16%-10.16M	-43.01%-11.07M	-108.38%-12.13M	1,203.20%110.32M	-447.00%-13.68M	-422.12%-13.05M
Cash from discontinued investing activities
Operating cash flow	-21.87%-82.22M	-39.53%-102.3M	-244.55%-287.78M	-65.54%-74.08M	-33.70%-72.92M	-9.48%-67.47M	-194.74%-73.32M	47.34%-83.52M	26.83%-44.75M	-65.04%-54.54M
Investing cash flow
Cash flow from continuing investing activities	-103.70%-4.18M	-24.59%-6.65M	-105.29%-10.23M	68.82%-2.49M	-100.65%-347K	-141.56%-2.05M	-103.73%-5.34M	171.11%193.25M	84.73%-7.98M	127.33%52.98M
Net PPE purchase and sale	70.21%-1.18M	-28.56%-6.65M	67.74%-11.96M	74.09%-2.07M	90.98%-745K	75.92%-3.97M	-19.18%-5.18M	6.88%-37.06M	-78.74%-7.98M	14.87%-8.26M
Net intangibles purchase and sale	---3M	--0	-99.00%-597K	---350K	72.67%-82K	--0	---165K	---300K	--0	---300K
Net business purchase and sale	----	----	--1.84M	---71K	--0	----	----	--0	--0	--0
Net investment purchase and sale	----	----	-99.79%480K	--0	----	----	----	199.42%230.61M	--0	133.42%61.55M
Cash from discontinued investing activities
Investing cash flow	-103.70%-4.18M	-24.59%-6.65M	-105.29%-10.23M	68.82%-2.49M	-100.65%-347K	-141.56%-2.05M	-103.73%-5.34M	171.11%193.25M	84.73%-7.98M	127.33%52.98M
Financing cash flow
Cash flow from continuing financing activities	6,848.03%263.12M	623.05%13.9M	-9.21%140.13M	-45.23%80.66M	2,200.60%53.77M	41.94%3.79M	-7.77%1.92M	-66.34%154.35M	3,779.24%147.26M	121.06%2.34M
Net issuance payments of debt	-8.33%-26K	-8.33%-26K	-751.11%-766K	-2,917.39%-694K	-4.35%-24K	-9.09%-24K	-9.09%-24K	99.30%-90K	-9.52%-23K	99.82%-23K
Net common stock issuance	--261.55M	--10.87M	-10.87%128.09M	-45.66%78.09M	--50M	--0	--0	-68.95%143.71M	--143.71M	----
Proceeds from stock option exercised by employees	-57.96%1.6M	56.73%3.05M	19.41%12.81M	-8.63%3.26M	60.55%3.79M	41.67%3.81M	-7.60%1.95M	27.11%10.72M	-6.52%3.57M	43.73%2.36M
Cash from discontinued financing activities
Financing cash flow	6,848.03%263.12M	623.05%13.9M	-9.21%140.13M	-45.23%80.66M	2,200.60%53.77M	41.94%3.79M	-7.77%1.92M	-66.34%154.35M	3,779.24%147.26M	121.06%2.34M
Net cash flow
Beginning cash position	-36.53%306.15M	-28.20%401.43M	89.31%559.11M	-14.56%397.21M	-10.19%416.82M	-6.90%482.38M	89.31%559.11M	10.55%295.35M	14.80%464.89M	-27.82%464.11M
Current changes in cash	368.85%176.72M	-23.88%-95.06M	-159.79%-157.88M	-95.67%4.09M	-2,600.26%-19.5M	-21.69%-65.73M	-134.44%-76.73M	837.02%264.07M	186.25%94.53M	100.33%780K
Effect of exchange rate changes	-165.19%-118K	-10,850.00%-219K	161.24%188K	140.39%124K	---115K	--181K	---2K	---307K	---307K	--0
End cash Position	15.82%482.75M	-36.53%306.15M	-28.20%401.43M	-28.20%401.43M	-14.56%397.21M	-10.19%416.82M	-6.90%482.38M	89.31%559.11M	89.31%559.11M	14.80%464.89M
Free cash flow	-20.95%-86.4M	-38.52%-108.95M	-148.45%-300.33M	-45.08%-76.49M	-16.87%-73.75M	8.53%-71.44M	-207.68%-78.66M	39.07%-120.88M	19.65%-52.73M	-47.60%-63.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall